Trethera Announces Prostate Cancer Poster Presentation at the American Association for Cancer Research Annual Meeting
Los Angeles, March 22, 2022 — Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide […]